Clinical Trial

To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors

Name: To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors — clinical trial record (NCT07338838)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To explore the safety, tolerability and pharmacokinetics of TQB3142 for injection in subjects with advanced malignant tumors

Protocol Amendment History 2 changes

critical Recruitment opened 2026-06-24

notable Trial sites expanded: 2 -> 5 locations 2026-06-24

Trial Details

NCT Number	NCT07338838
Lead Sponsor	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions	Advanced Malignant Tumors
Enrollment	66 participants
Start Date	2026-02-26
Primary Completion	2027-12 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-23